###begin article-title 0
###xml 31 38 31 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 72 80 <span type="species:ncbi:9606">Patients</span>
MicroRNA Fingerprints Identify miR-150 as a Plasma Prognostic Marker in Patients with Sepsis
###end article-title 0
###begin p 1
Conceived and designed the experiments: CV GC. Performed the experiments: SR MS AV MF MN EB MHF. Analyzed the data: CV SR MF MN EB MN GC. Contributed reagents/materials/analysis tools: ST MP OS DT CEBR. Wrote the paper: CV SR GC.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 495 503 <span type="species:ncbi:9606">patients</span>
The physiopathology of sepsis continues to be poorly understood, and despite recent advances in its management, sepsis is still a life-threatening condition with a poor outcome. If new diagnostic markers related to sepsis pathogenesis will be identified, new specific therapies might be developed and mortality reduced. Small regulatory non-coding RNAs, microRNAs (miRNAs), were recently linked to various diseases; the aim of our prospective study was to identify miRNAs that can differentiate patients with early-stage sepsis from healthy controls and to determine if miRNA levels correlate with the severity assessed by the Sequential Organ Failure Assessment (SOFA) score.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 97 104 97 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 106 113 106 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-182</italic>
###xml 115 125 115 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-342-5p</italic>
###xml 131 138 131 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-486</italic>
###xml 297 304 297 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 647 654 647 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 181 189 <span type="species:ncbi:9606">patients</span>
###xml 367 375 <span type="species:ncbi:9606">patients</span>
By using genome-wide miRNA profiling by microarray in peripheral blood leukocytes, we found that miR-150, miR-182, miR-342-5p, and miR-486 expression profiles differentiated sepsis patients from healthy controls. We also proved by quantitative reverse transcription-polymerase chain reaction that miR-150 levels were significantly reduced in plasma samples of sepsis patients and correlated with the level of disease severity measured by the SOFA score, but were independent of the white blood counts (WBC). We found that plasma levels of tumor necrosis factor alpha, interleukin-10, and interleukin-18, all genes with sequence complementarity to miR-150, were negatively correlated with the plasma levels of this miRNA. Furthermore, we identified that the plasma levels ratio for miR-150/interleukin-18 can be used for assessing the severity of the sepsis.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
###xml 16 23 16 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 175 182 175 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 236 244 <span type="species:ncbi:9606">patients</span>
We propose that miR-150 levels in both leukocytes and plasma correlate with the aggressiveness of sepsis and can be used as a marker of early sepsis. Furthermore, we envision miR-150 restoration as a future therapeutic option in sepsis patients.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 201 204 201 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007405-Hotchkiss1">[1]</xref>
###xml 205 208 205 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007405-Dombrovskiy1">[3]</xref>
###xml 676 679 676 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007405-Bone1">[2]</xref>
###xml 878 881 878 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007405-Dombrovskiy1">[3]</xref>
###xml 1424 1427 1424 1427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007405-Hutchins1">[4]</xref>
###xml 1429 1432 1429 1432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007405-Lichtenstern1">[5]</xref>
###xml 1596 1599 1596 1599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007405-Hutchins1">[4]</xref>
###xml 1858 1861 1858 1861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007405-Lichtenstern1">[5]</xref>
###xml 838 846 <span type="species:ncbi:9606">patients</span>
###xml 1521 1529 <span type="species:ncbi:9606">patients</span>
###xml 1997 2005 <span type="species:ncbi:9606">patients</span>
Sepsis represents a serious medical condition characterized by a whole-body inflammatory state called systemic inflammatory response syndrome, which is caused by a suspected or proven severe infection [1]-[3]. Severe sepsis occurs when sepsis leads to dysfunction of at least one organ or system due to hypoperfusion or hypotension, while septic shock is associated with refractory arterial hypotension despite aggressive fluid resuscitation and with multiple organ dysfunction syndrome. The criteria for diagnosis of sepsis and severity were established by the American College of Chest Physicians and the Society of Critical Care Medicine Consensus in 1992 and remain valid [2]. Despite recent advances in management, sepsis is still a life-threatening condition with a poor outcome and is the major cause of death among critically ill patients in intensive care units (ICUs) [3]. The physiopathology of sepsis continues to be poorly understood and, consequently, only a few specific therapies are available to treat this condition. Several scoring systems are used, including the sequential organ failure assessment (SOFA) score, but these systems evaluate clinical parameters related to the associated multiple organ dysfunction syndrome and do not include any factor involved in pathogenesis of the sepsis itself. Intraabdominal sepsis after abdominal surgery is responsible for approximately 13% of all ICU admissions [4], [5]. Studies have suggested that clearance of intraperitoneal sepsis may be beneficial when patients develop signs of intraabdominal sepsis after abdominal procedures [4]. However, the diagnosis of postoperative infections is difficult because clinical signs (e.g., pain, changes in level of consciousness, etc.) and laboratory findings, such as elevated acute-phase reactants (e.g., C-reactive protein), or fever are unspecific [5]. Therefore, new diagnostic markers could offer advantages over routine clinical and laboratory parameters in identifying postoperative patients with early-stage sepsis.
###end p 9
###begin p 10
###xml 219 222 219 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007405-Calin1">[6]</xref>
###xml 224 227 224 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007405-Nicoloso1">[7]</xref>
###xml 294 297 294 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007405-Perkins1">[8]</xref>
###xml 308 311 308 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007405-Wang1">[9]</xref>
###xml 340 344 340 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007405-Wu1">[10]</xref>
###xml 364 368 364 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007405-Anglicheau1">[11]</xref>
###xml 577 581 577 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007405-Ambros1">[12]</xref>
###xml 726 730 726 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007405-Ambros1">[12]</xref>
###xml 795 802 795 802 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-155</italic>
###xml 807 815 807 815 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-125b</italic>
###xml 854 858 854 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007405-Tili1">[13]</xref>
###xml 974 981 974 981 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-155</italic>
###xml 1004 1012 1004 1012 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-125b</italic>
###xml 1206 1213 1206 1213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-155</italic>
###xml 1218 1226 1218 1226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-125b</italic>
###xml 1323 1327 1323 1327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007405-Tili1">[13]</xref>
###xml 206 211 <span type="species:ncbi:9606">human</span>
###xml 768 772 <span type="species:ncbi:10090">mice</span>
###xml 914 919 <span type="species:ncbi:10090">mouse</span>
###xml 1065 1069 <span type="species:ncbi:10090">mice</span>
###xml 1442 1450 <span type="species:ncbi:9606">patients</span>
###xml 1679 1687 <span type="species:ncbi:9606">patients</span>
Recently, a new category of non-coding RNAs (RNAs that do not codify for proteins), named microRNAs (miRNAs), was found to be involved in the initiation, progression, and metastasis of any type of analyzed human cancer [6], [7]; miRNAs also play a role in other diseases, such as schizophrenia [8], diabetes [9], inflammatory bowel disease [10], and renal disease [11]. miRNAs are small RNAs that regulate expression of protein-coding genes by direct (sequence complementarity) interaction with and degradation of messenger RNAs (mRNAs) or by inhibition of protein translation [12]. miRNAs have been implicated in a wide array of cellular and developmental processes such as cell proliferation, apoptosis, and differentiation [12]. In a previous experimental study on mice, we demonstrated that miR-155 and miR-125b play a role in innate immune response [13]. We found that lipopolysaccharide (LPS) stimulation of mouse Raw 264.7 macrophages resulted in the upregulation of miR-155 and downregulation of miR-125b levels. The same changes also occurred when C57BL/6 mice were intraperitonealy injected with LPS. The data suggest that the LPS/tumor necrosis factor-alpha- (TNF-alpha) dependent regulation of miR-155 and miR-125b may be implicated in the response to endotoxin shock, thus offering new targets for drug design [13]. As a continuation of our previous work, in the present study we interrogated miRNA expression in a set of sepsis patients by performing genome-wide profiling by microarray in leukocytes followed by quantitative reverse transcription-polymerase chain reaction (qRT-PCR) on plasma samples; we then compared the levels of miRNA expression in the sepsis patients with the miRNA levels in a series of healthy controls. Furthermore, we identified a plasma miRNA ratio (miR-150/IL-18) that can be used for assessing the severity of the sepsis.
###end p 10
###begin title 11
Materials and Methods
###end title 11
###begin title 12
###xml 7 15 <span type="species:ncbi:9606">Patients</span>
Sepsis Patients and Healthy Controls
###end title 12
###begin p 13
###xml 246 247 246 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 275 276 275 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 565 572 565 572 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1</bold>
###xml 565 572 565 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007405-t001"><bold>Table 1</bold></xref>
###xml 75 83 <span type="species:ncbi:9606">patients</span>
###xml 142 147 <span type="species:ncbi:9606">women</span>
###xml 151 154 <span type="species:ncbi:9606">men</span>
###xml 231 236 <span type="species:ncbi:9606">women</span>
###xml 241 244 <span type="species:ncbi:9606">men</span>
###xml 347 355 <span type="species:ncbi:9606">patients</span>
###xml 656 663 <span type="species:ncbi:9606">patient</span>
###xml 747 755 <span type="species:ncbi:9606">patients</span>
###xml 935 943 <span type="species:ncbi:9606">patients</span>
###xml 1013 1021 <span type="species:ncbi:9606">patients</span>
In the present study, we prospectively collected 24 samples from 17 sepsis patients (mean age +/- standard deviation (SD) = 55.4+/-17.13 y; 9 women, 8 men) and 32 samples from 32 healthy controls (mean age+/-SD = 49.2+/-20.12 y; 9 women, 23 men; p = 0.267 for age variation; p = 0.081 for gender) of peripheral blood leukocytes and/or plasma. All patients were admitted between November 2006 and March 2008 to the ICU at Fundeni University Hospital, Bucharest, Romania, after various types of abdominal surgeries (n = 8) or non-surgical related infections (n = 9) (Table 1). SOFA scores were assessed at day 1 and day 7; we also scored the outcome of each patient (alive or dead). The controls were healthy individuals selected from blood donors, patients' families, or research staff involved in the present study. "Healthy" was defined as the absence of any type of infection or known medical condition at the time of the study. All patients and controls were white Caucasians (according to medical records for patients and interview for controls).
###end p 13
###begin title 14
###xml 76 84 <span type="species:ncbi:9606">Patients</span>
Clinical Data, SOFA Score, and Plasma Ratio miR-150/192 for Analyzed Sepsis Patients.
###end title 14
###begin p 15
Sample collected only at day 7.; SP, sepsis; SSP, severe sepsis; SoP, septic shock.
###end p 15
###begin p 16
###xml 332 339 332 339 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1</bold>
###xml 332 339 332 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007405-t001"><bold>Table 1</bold></xref>
###xml 70 78 <span type="species:ncbi:9606">patients</span>
###xml 146 154 <span type="species:ncbi:9606">patients</span>
###xml 189 197 <span type="species:ncbi:9606">patients</span>
###xml 286 293 <span type="species:ncbi:9606">patient</span>
We obtained both peripheral blood leukocytes and plasma for 10 sepsis patients and 12 controls and only plasma samples for the remaining 7 sepsis patients and 20 controls. For seven of the patients, we collected plasma samples at two time points (days 1 and 7 after admission); for one patient, we collected a sample only at day 7 (Table 1). Peripheral blood leukocytes were obtained from 5 ml blood, and total RNA was purified using Trizol (Invitrogen, Carlsbad, CA). RNA quality was assessed by Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA), and only RNA with an RNA integrity number (a measure of RNA quality) higher than 7 was used for the expression-profiling study. Total RNA in plasma was isolated using Total RNA purification Kit (Norgen Biotek Corporation, Ontario, Canada) according to the manufacturer's instructions.
###end p 16
###begin title 17
Ethics Statement
###end title 17
###begin p 18
###xml 197 209 <span type="species:ncbi:9606">participants</span>
For de-identification, the samples were codified S (for sepsis) and C (for controls) followed by a codified number to protect the privacy of individuals during all the further molecular study. All participants gave informed written consent to participate in this study and the samples were processed under approval of the Fundeni Hospital Ethics Committee.
###end p 18
###begin title 19
###xml 12 17 <span type="species:ncbi:9606">Human</span>
Genome-wide Human miRNA Expression Detection
###end title 19
###begin p 20
###xml 78 83 <span type="species:ncbi:9606">human</span>
###xml 188 193 <span type="species:ncbi:9606">human</span>
Sixteen RNA samples from leukocyte (8 control, 8 sepsis) were hybridized on a human miRNA microarray (G4470A, Agilent Technologies). This microarray consisted of 60-mer DNA probes for 470 human miRNAs, sourced from the Sanger miRBase public database (Release 9.1). One-color miRNA expression was performed according to the manufacturer's procedure. Briefly, total RNA was obtained from samples by using the Trizol reagent (Invitrogen). Labeled miRNAs were obtained from 500 ng of total RNA through the ligation of a 5'-cytidine bisphosphate-Cy3 (pCp-Cy3, Agilent Technologies) group at the 3'-end of each miRNA. To enhance the T4 RNA-ligase (Promega, Madison, WI) efficiency, we had previously treated total RNA with alkaline phosphatase (Amersham, Piscataway, NJ) at 37degreesC for 30 min. Labeled miRNAs were purified on chromatography columns (Micro Biospin 6, Biorad Laboratories, Hercules, CA) and then hybridized on a microarray. Hybridizations were performed at 55degreesC for 17 h in a rotating oven. Images at 5-microm resolution were generated by a scanner (Agilent Technologies), and the Feature Extraction 9.5 software (Agilent Technologies) was used to obtain the microarray raw data.
###end p 20
###begin title 21
Microarray Data Analysis
###end title 21
###begin p 22
###xml 972 973 970 971 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 981 982 979 980 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Microarray results were independently analyzed in two distinct ways by MF in Ferrara, Italy and by SR in Houston, TX, respectively. First, using GeneSpring GX software version 7.3 (Agilent Technologies), we preprocessed data files with the plug-in for the Agilent Feature Extraction software results. Data transformation was applied to set all negative raw values at 5.0, followed by on-chip and on-gene median normalization. We filtered data for low gene expression so that only probes expressed (flagged as "present") in at least one sample were kept; probes that did not change between samples, i.e., identified as having an expression value across all samples between median+/-1.5, were removed. Next, samples were grouped according to their status and then compared. Differentially expressed genes were selected as having a 2-fold expression difference between their geometrical mean in the two groups of interest (sepsis and control) and a statistically significant p-value (p<0.05) by analysis of variance statistics.
###end p 22
###begin p 23
###xml 576 577 574 575 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 935 936 933 934 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1032 1033 1030 1031 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Independently, a second type of data analysis was performed by using extracted fluorescence intensity values (Agilent Feature Extraction) from all 16 hybridizations. The data were imported into Biometric Research Branch (BRB) array tool version 3.7.0 () for subsequent microarray analysis. MiRNAs with less than 20% expression data with at least 1.5-fold (expression between median+/-1.5) change and probes with values missing from more than 50% of the arrays were removed, leaving 88 probes to be included in data analysis. Absent calls were assigned at a threshold of 7 (log2) before statistical analysis. Intensities were normalized using average factors scaled to the median array intensities over the entire array by using the median array as a reference. This filtering method was decided a priori to eliminate probes whose miRNA expression levels were thought to be unreliable. Class-comparison analysis using two-sided Student t-tests identified miRNAs that were differentially expressed between sepsis and control samples (p<0.05) and had a false discovery rate (FDR) of less than 9%. Cluster analysis was done with Cluster 3.0 () and displayed using TreeView program (). Microarray raw data are MIAME compliant and were deposited in the public repository (ArrayExpress accession: E-TABM-713).
###end p 23
###begin title 24
qRT-PCR for miRNA Expression
###end title 24
###begin p 25
###xml 348 355 348 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-192</italic>
###xml 467 475 467 471 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-&#916;CT</sup>
###xml 490 491 482 483 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sub>
###xml 501 506 493 498 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miRNA</sub>
###xml 516 532 508 524 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">internal control</sub>
###xml 813 814 805 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 821 822 813 814 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
MiRNA levels were detected by qRT-PCR using the TaqMan MicroRNA Assays (Applied Biosystems, Foster City, CA), according to the manufacturer's instructions. Experiments were performed in triplicate wells. To normalize the expression levels of target genes, we used U6B small nuclear RNA for the experiment performed with RNAs from leukocytes, while miR-192 was used for plasma RNA normalization. The relative expression of each miRNA was calculated from the equation 2-DeltaCT, where Delta CT = mean CtmiRNA - mean Ctinternal control (where Ct is the threshold cycle for a sample). Briefly, the relative abundance of each miRNA was calculated as the ratio of the value from sepsis to the value from controls, producing a fold-change value. Data for sepsis/control samples were compared using the two-sided Student t-test (p<0.05).
###end p 25
###begin title 26
MiRNA Target Prediction
###end title 26
###begin p 27
###xml 1001 1006 <span type="species:ncbi:9606">human</span>
We used two independent and complementary ways to predict miRNA targets. First, we used miRGen at , which contains animal miRNA targets according to combinations of the widely used target-prediction programs miRanda, TargetScanS, and PicTar and experimentally supported targets from TarBase. Second, we used RNA22 at , a pattern-based method for identifying miRNA-target sites and their corresponding RNA/RNA complexes, by using not only the 3' untranslated region of the mRNA but also the full messenger sequence. We used the Database for Annotation, Visualization, and Integrated Discovery () to identify the pathway distribution of predicted targets. These pathways were presented according to the Kyoto Encyclopedia of Genes and Genomes (KEGG) database (). This is a database of biological systems, consisting of the genetic building blocks of genes and proteins; the identified pathways are composed by molecular interactions and reaction networks for metabolism, various cellular processes, and human diseases.
###end p 27
###begin title 28
Enzyme-Linked Immunosorbent Assay (ELISA)
###end title 28
###begin p 29
###xml 503 510 503 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Results</xref>
###xml 673 674 673 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 724 725 724 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 732 733 732 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 51 56 <span type="species:ncbi:9606">human</span>
###xml 132 137 <span type="species:ncbi:9606">human</span>
###xml 200 205 <span type="species:ncbi:9606">human</span>
Due to the availability of material, the levels of human tumor necrosis factor alpha (TNF-alpha, 12 control and 11 sepsis samples), human interleukin-10 (IL-10, 11 control and 20 sepsis samples), and human interleukin-18 (IL-18, 22 control and 18 sepsis samples) were measured by ELISA in undiluted plasma samples. Commercially available ELISA kits for TNF-alpha and IL-18 (R & D Systems, Minneapolis, MN) and IL-10 (BD Biosciences, San Jose, CA) were used according to the manufacturers' instructions. Results were read at an optical density of 450 nm using a Spectra Max Plus plate reader (Molecular Devices, Sunnyvale, CA). Measurements were performed in duplicate, and p-values were computed using the two-sided Student t-test (p<0.05).
###end p 29
###begin title 30
Statistical Analysis
###end title 30
###begin p 31
###xml 120 121 120 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 276 277 276 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 430 431 430 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 110 118 <span type="species:ncbi:9606">patients</span>
The t-test on microarray data identified miRNAs that were differentially expressed between sepsis and control patients (p<0.01, FDR<0.09). We also identified miRNAs and cytokines that were differentially expressed in sepsis and control subjects for qRT-PCR data using t-test (p<0.05). Matlab 6.5 () analysis was used for the Pearson's correlation. All statistical tests were two-sided, and statistical significance was defined as p<0.05.
###end p 31
###begin title 32
Results
###end title 32
###begin title 33
###xml 80 88 <span type="species:ncbi:9606">Patients</span>
MiRNA Genome-Wide Profiling in Peripheral Blood Leukocytes Differentiate Sepsis Patients from Healthy Controls
###end title 33
###begin p 34
###xml 302 310 302 310 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1</bold>
###xml 302 310 302 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007405-g001"><bold>Figure 1</bold></xref>
###xml 560 581 560 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Materials and Methods</xref>
###xml 793 802 793 802 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1A</bold>
###xml 793 802 793 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007405-g001"><bold>Figure 1A</bold></xref>
###xml 859 866 859 866 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 868 875 868 875 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-182</italic>
###xml 877 887 877 887 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-342-5p</italic>
###xml 892 899 892 899 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-486</italic>
###xml 996 997 996 997 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1017 1024 1015 1022 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-486</italic>
###xml 1029 1036 1027 1034 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-182</italic>
###xml 1063 1070 1061 1068 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 1075 1085 1073 1083 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-342-5p</italic>
###xml 1134 1141 1132 1139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-155</italic>
###xml 1146 1154 1144 1152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-125b</italic>
###xml 1262 1266 1260 1264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007405-Tili1">[13]</xref>
###xml 34 42 <span type="species:ncbi:9606">patients</span>
###xml 173 178 <span type="species:ncbi:9606">human</span>
###xml 211 219 <span type="species:ncbi:9606">patients</span>
###xml 1115 1123 <span type="species:ncbi:9606">patients</span>
###xml 1244 1249 <span type="species:ncbi:10090">mouse</span>
###xml 1339 1347 <span type="species:ncbi:9606">patients</span>
To determine if miRNA patterns in patients with sepsis are significantly different from those in healthy controls, we first used microarray to compare the expression of 470 human miRNAs in leukocytes from eight patients at day 1 (first day in ICU) with expression profiles from eight healthy controls (Figure 1). As array data analyses could be performed by several methods that could reciprocally confirm each other, independent investigators performed this essential step using two different tools-the BRB array and GeneSpring GX software, respectively (see Materials and Methods). We found that a set of 17 miRNAs correctly differentiated 100% of the samples belonging to the two groups (sepsis and control), meaning that expression of these miRNAs was a good classifier for each category (Figure 1A). In both types of analyses, we identified four miRNAs- miR-150, miR-182, miR-342-5p and miR-486 -whose expression levels differed by at least a factor of 2 between sepsis and healthy samples (p</=0.01; FDR<0.08): miR-486 and miR-182 were overexpressed, while miR-150 and miR-342-5p were downregulated in sepsis patients. Of note, miR-155 and miR-125b, the former upregulated, while the latter down-regulated by LPS stimulation of Raw 264.7 mouse macrophages [13], were not statistically significant dysregulated in the analyzed set of patients.
###end p 34
###begin title 35
###xml 54 62 <span type="species:ncbi:9606">Patients</span>
Leukocyte miRNA Signature Differentiates Early Sepsis Patients from Healthy Controls.
###end title 35
###begin p 36
###xml 86 89 86 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 126 127 126 127 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 191 192 191 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 444 447 444 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
(A) The cluster shows a perfect separation between the two classes of samples (sepsis vs. controls). The miRNA expression (log2) cluster shows differentially expressed genes as determined by t-test analysis. Yellow indicates high expression, and blue indicates low expression, relative to the median. (B) Fold change by qRT-PCR and array is shown for the leukocyte signature miRNAs. The most conspicuous differentially expressed miRNAs (sepsis vs. control) identified by both BRB array tools and GeneSpring GX software and also by qRT-PCR in leukocyte cells are shown.
###end p 36
###begin p 37
###xml 260 267 260 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 269 276 269 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-182</italic>
###xml 278 288 278 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-342-5p</italic>
###xml 294 301 294 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-486</italic>
###xml 478 485 478 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-486</italic>
###xml 573 582 573 582 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1B</bold>
###xml 573 582 573 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007405-g001"><bold>Figure 1B</bold></xref>
###xml 550 558 <span type="species:ncbi:9606">patients</span>
For independent confirmation, we performed a distinct type of quantification, qRT-PCR amplification for the active miRNA molecule in a set of 10 sepsis and 12 control leukocyte samples, including the 16 samples analyzed by the array. qRT-PCR was performed for miR-150, miR-182, miR-342-5p, and miR-486 using the same total RNA as for the array; we used U6B as control. For all four genes we confirmed the same variation identified by the array, and in all instances, except for miR-486, with both methods the ratio was at least 2-fold between sepsis patients and controls (Figure 1B). Therefore, we were able to identify a miRNA signature that was associated with early stages of sepsis (on first day of admission to ICU). To get a higher confidence, we independently confirmed this signature using two types of statistical analysis and two types of miRNA quantification.
###end p 37
###begin title 38
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MiR-150</italic>
###xml 61 69 <span type="species:ncbi:9606">Patients</span>
MiR-150 Levels in Plasma Are Significantly Reduced in Sepsis Patients Compared with Controls and Correlate with the Level of Sepsis Severity
###end title 38
###begin p 39
###xml 78 82 78 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007405-Cortez1">[14]</xref>
###xml 120 127 120 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 210 219 210 219 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1B</bold>
###xml 210 219 210 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007405-g001"><bold>Figure 1B</bold></xref>
###xml 267 274 267 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 603 610 603 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-192</italic>
###xml 615 621 615 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let-7a</italic>
###xml 774 781 774 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-192</italic>
###xml 853 862 853 862 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2A</bold>
###xml 853 862 853 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007405-g002"><bold>Figure 2A</bold></xref>
###xml 879 886 879 886 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 1039 1040 1039 1040 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1053 1054 1053 1054 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1079 1088 1079 1088 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2A</bold>
###xml 1079 1088 1079 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007405-g002"><bold>Figure 2A</bold></xref>
###xml 1119 1126 1119 1126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 1152 1159 1152 1159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-192</italic>
###xml 1328 1335 1328 1335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 1423 1432 1423 1432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007405.s001">Figure S1</xref>
###xml 1423 1432 1423 1432 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="supplementary-material" rid="pone.0007405.s001">Figure S1</xref></bold>
###xml 1535 1542 1535 1542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MiR-182</italic>
###xml 1547 1557 1547 1557 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-342-5p</italic>
###xml 1675 1685 1675 1685 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-342-5p</italic>
###xml 1703 1710 1703 1710 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-182</italic>
###xml 1863 1870 1863 1870 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-182</italic>
###xml 1881 1891 1881 1891 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-342-5p</italic>
###xml 942 950 <span type="species:ncbi:9606">patients</span>
###xml 1413 1421 <span type="species:ncbi:9606">patients</span>
Recently, miRNA expression in plasma was detected by using qRT-PCR techniques [14]. We focused for the present study on miR-150, as it has the highest levels of dysregulation in sepsis samples versus controls (Figure 1B). Therefore, we investigated the expression of miR-150 in plasma by performing qRT-PCR on 24 sepsis (including 16 at day 1 and 8 at day 7) and 32 control samples. We initially used U6 and U6B for the selection of the normalizer gene, but since these RNAs were degraded in plasma we could not obtain reproducible results in triplicate experiments. Thereafter, we analyzed two miRNAs (miR-192 and let-7a) that, according to the array data, had no variance in expression between sepsis samples and controls. The best reproducible results were obtained with miR-192; therefore, we used the expression of this miRNA as a reference value (Figure 2A). We found that miR-150 was significantly down regulated in plasma from sepsis patients compared with controls at both days 1 and 7 at highly statistically significant values (p = 0.001 and p = 0.005, respectively) (Figure 2A). Therefore, plasma levels of miR-150 (expressed as ratio with miR-192) reproduced the variations in leukocytes, and represent a reliable indicator of early sepsis. Importantly, we did not find any correlation between the plasma levels of miR-150 and the number of leukocytes (expressed as white blood count, WBC) in sepsis patients (Figure S1), meaning that this downregulation is not just a biomarkers for the amount of circulating leukocytes. MiR-182 and miR-342-5p, differentially expressed in leukocytes were studied also in plasma; the trend of variation was as in leukocytes for miR-342-5p and opposite for miR-182, and both of them were not significantly differentially expressed, probably due to the small number of sepsis samples with detectable expression (4 for miR-182 and 3 for miR-342-5p).
###end p 39
###begin title 40
###xml 16 23 16 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 57 65 <span type="species:ncbi:9606">Patients</span>
Plasma Level of miR-150 is Significantly Lower in Sepsis Patients as in Controls.
###end title 40
###begin p 41
###xml 27 34 27 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-192</italic>
###xml 223 230 223 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 252 259 252 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-192</italic>
###xml 453 460 453 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 465 472 465 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-192</italic>
###xml 642 650 642 646 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-&#916;Ct</sup>
###xml 784 791 780 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 879 886 875 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-192</italic>
###xml 914 921 910 917 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 926 933 922 929 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-192</italic>
###xml 96 104 <span type="species:ncbi:9606">patients</span>
###xml 493 501 <span type="species:ncbi:9606">patients</span>
###xml 602 610 <span type="species:ncbi:9606">patients</span>
###xml 683 691 <span type="species:ncbi:9606">patients</span>
###xml 954 962 <span type="species:ncbi:9606">patients</span>
(A) Microarray analysis of miR-192 levels in leukocytes found no variance in expression between patients and controls; qRT-PCR confirmed the same finding in plasma. Therefore, we used this miRNA as reference and normalized miR-150 levels in respect to miR-192 and found significant downregulation at both day 1 and day 7. Mean Ct plus standard deviation have been reported. The lower panel represents the combination of data from the upper two. (B) The miR-150 and miR-192 levels of 16 sepsis patients are plotted by their mean Ct values at day 1 after ICU admission. The round grey dots represent the patients with lower expression levels (2-DeltaCt) and lower SOFA scores than the patients identified by square black dots. The grey shaded region indicates the threshold to classify miR-150, showing a clear division between samples with high and low expression levels based on miR-192 as the normalizer. (C) The miR-150 and miR-192 levels of 16 sepsis patients are plotted by their miR-150/miR-192 relative expression values at day 1 after ICU admission related to the respective SOFA score. Interpolation line was reported.
###end p 41
###begin p 42
###xml 30 37 30 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 436 443 432 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 448 455 444 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-192</italic>
###xml 467 476 463 472 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2B</bold>
###xml 467 476 463 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007405-g002"><bold>Figure 2B</bold></xref>
###xml 699 700 693 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 711 718 705 712 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1</bold>
###xml 711 718 705 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007405-t001"><bold>Table 1</bold></xref>
###xml 772 779 766 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 895 904 889 898 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2C</bold>
###xml 895 904 889 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007405-g002"><bold>Figure 2C</bold></xref>
###xml 990 999 984 993 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007405.s002">Figure S2</xref>
###xml 990 999 984 993 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="supplementary-material" rid="pone.0007405.s002">Figure S2</xref></bold>
###xml 1101 1108 1095 1102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 1170 1181 1164 1175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150/192</italic>
###xml 1330 1337 1324 1331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 1410 1411 1404 1405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1555 1556 1549 1550 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1707 1714 1701 1708 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1</bold>
###xml 1707 1714 1701 1708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007405-t001"><bold>Table 1</bold></xref>
###xml 1757 1764 1751 1758 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 62 70 <span type="species:ncbi:9606">patients</span>
###xml 499 507 <span type="species:ncbi:9606">patients</span>
###xml 592 600 <span type="species:ncbi:9606">patients</span>
###xml 731 739 <span type="species:ncbi:9606">patients</span>
###xml 980 988 <span type="species:ncbi:9606">patients</span>
###xml 1071 1079 <span type="species:ncbi:9606">patients</span>
###xml 1145 1152 <span type="species:ncbi:9606">patient</span>
###xml 1490 1498 <span type="species:ncbi:9606">patients</span>
###xml 1594 1602 <span type="species:ncbi:9606">patients</span>
###xml 1825 1833 <span type="species:ncbi:9606">patients</span>
In studying the expression of miR-150 in plasma of the sepsis patients (qRT-PCR data), we noticed a correlation between the fold-difference value and SOFA score and/or associated severity of sepsis (grades labeled as sepsis, severe sepsis, and septic shock). Interestingly, by considering an 8.5-fold cutoff value for the expression ratio miR-150/miR-192 (meaning at least three amplification cycles' difference for the DeltaCt between miR-150 and miR-192) at day 1 (Figure 2B), we found that the 6 patients with higher ratios (15.07 to 97.24) had significantly lower SOFA scores than the 10 patients with lower ratios (0.44 to 8.20) (2.83+/-2.64 versus 7.80+/-5.41 mean ratio +/- SD, respectively; p = 0.028) (Table 1). All three patients with septic shock had levels of miR-150 lower than 8.5. Furthermore the miR-150/miR-192 relative expression was negatively correlated with the SOFA score (Figure 2C) and this ratio decreased from the sepsis to severe sepsis to sepsis shock patients (Figure S2). These data are in agreement with our initial observation that sepsis patients have lower levels of miR-150 than healthy controls; in fact, the patient with the highest miR-150/192 ratio (97.24) had the lowest SOFA score at both days 1 and 7. Further strengthening this conclusion, we did not find any significant differences in miR-150 expression between day 1 and day 7 (43.98+/-29.35 versus 28.08+/-25.32; p not significant), as the SOFA score was quite similar for this limited set of patients (day 1+/-SD = 3.28+/-2.69 versus 1.86+/-2.61 for day 7; p not significant). Also, six of seven patients with measurements on both day 1 and day 7 had miR-150/miR-192 ratios concordant with their SOFA scores (Table 1). Therefore, consistently lower levels of miR-150 were found in both leukocyte and plasma samples from sepsis patients than in healthy controls, and lower expression was associated with poor clinical condition as indicated by the SOFA score.
###end p 42
###begin title 43
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MiR-150</italic>
MiR-150 Expression Profile Is Correlated with Expression of Immune System Genes
###end title 43
###begin p 44
###xml 62 69 62 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 281 288 281 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 546 553 546 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 763 767 763 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007405-Grobmyer1">[15]</xref>
###xml 768 772 768 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007405-MelS1">[17]</xref>
###xml 914 921 914 921 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 1076 1083 1076 1083 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 2</bold>
###xml 1076 1083 1076 1083 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007405-t002"><bold>Table 2</bold></xref>
###xml 1159 1163 1159 1163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007405-Pereira1">[18]</xref>
###xml 1210 1214 1210 1214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007405-George1">[19]</xref>
###xml 1239 1243 1239 1243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007405-Das1">[20]</xref>
###xml 1245 1249 1245 1249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007405-Barkhausen1">[21]</xref>
###xml 1263 1267 1263 1267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007405-Koff1">[22]</xref>
###xml 1278 1282 1278 1282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007405-Weichhart1">[23]</xref>
###xml 1459 1463 1459 1463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007405-Nmeth1">[24]</xref>
###xml 1465 1469 1465 1469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007405-Abe1">[25]</xref>
###xml 1588 1595 1588 1595 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 1609 1618 1609 1618 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3A</bold>
###xml 1609 1618 1609 1618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007405-g003"><bold>Figure 3A</bold></xref>
###xml 1620 1627 1620 1627 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 1913 1920 1913 1920 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 742 750 <span type="species:ncbi:9606">patients</span>
###xml 1450 1458 <span type="species:ncbi:9606">patients</span>
###xml 1924 1931 <span type="species:ncbi:9606">patient</span>
As the next step, we tried to understand if the variations in miR-150 expression were only bystanders for other unknown causal effects or if they were linked to the pathogenesis of this disease. One way to do this was to identify correlations in clinical samples between levels of miR-150 expression and that of important protein-coding genes involved in the pathogenesis of sepsis. Dysregulation of miRNA levels would be anticipated to affect the translation of multiple protein-coding genes. Therefore, first we performed target prediction for miR-150 by using miRGen and found that among the predicted targets, at least 20 genes were functionally related to immune system processes; among these was IL-18, which is reportedly increased in patients with sepsis [15]-[17]. Using the Database for Annotation, Visualization, and Integrated Discovery () to identify overrepresented pathways, we found that predicted miR-150 targets were significantly (p<0.05) clustered in a few KEGG pathways, and the five most overrepresented pathways were all known to be involved in sepsis (Table 2): MAPK inhibition improves survival in endotoxin shock and prevents sepsis [18]; Wnt has a role in regulation of inflammation [19]; and insulin resistance [20], [21], ErbB (EGFR) [22], and mTOR [23] are related to immune and inflammatory response. As it is well known that IL-10 and TNF-alpha play an important role in immune response and are dysregulated in sepsis patients [24], [25], we checked by using an additional target prediction program (RNA22) to identify possible regions of interaction with miR-150. As shown in Figure 3A, miR-150 has regions of complementarity to IL-10, TNF-alpha, and IL-18 mainly in the 5'-end, the most extended with IL-18. These data suggest possible direct interactions and, more important for our clinical study, suggest possible negative correlations between the expression of cytokines and miR-150 in patient samples.
###end p 44
###begin title 45
###xml 46 53 46 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
Negative Correlation Between Plasma Levels of miR-150 and Cytokines.
###end title 45
###begin p 46
###xml 39 46 39 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 187 194 187 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 295 302 295 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 539 546 539 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 606 613 <span type="species:ncbi:9606">patient</span>
###xml 617 624 <span type="species:ncbi:9606">patient</span>
(A) The complementary sequence between miR-150 and the mRNAs of TNF-alpha, IL-10, and IL-18 is shown. Complementary sequences are reported, as well as the relative folding energy between miR-150 and mRNAs by using RNA22. (B) ELISA determination for plasma markers of sepsis and correlation with miR-150 expression in plasma are depicted in the graphs. The left panels show IL-10, IL-18 and TNF-alpha measurements by ELISA in plasma, mean Ct +/- standard deviation have been reported. The right panels show the negative correlation between miR-150 and IL-10, IL-18 and TNF-alpha, respectively. Values, on a patient by patient basis, have been reported for each cytokine studied.
###end p 46
###begin title 47
###xml 38 45 38 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 72 73 72 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="nt102">*</xref>
The Most Overrepresented Pathways for miR-150 targets According to KEGG *.
###end title 47
###begin p 48
###xml 110 117 110 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
- Count, number of potential target genes in the pathway; %, percentage of pathway genes that are targeted by miR-150. The gene name is presented as in NCBI at .
###end p 48
###begin p 49
###xml 287 288 287 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 298 299 298 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 314 315 314 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 342 349 342 349 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 3</bold>
###xml 342 349 342 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007405-t003"><bold>Table 3</bold></xref>
###xml 406 413 406 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 440 450 440 450 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figures 3B</bold>
###xml 440 450 440 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007405-g003"><bold>Figures 3B</bold></xref>
###xml 685 692 685 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 713 720 713 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-192</italic>
###xml 971 978 971 978 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 1146 1147 1146 1147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1231 1239 1231 1239 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4</bold>
###xml 1231 1239 1231 1239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007405-g004"><bold>Figure 4</bold></xref>
###xml 1366 1373 1366 1373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 1462 1469 1462 1469 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 264 272 <span type="species:ncbi:9606">patients</span>
###xml 417 425 <span type="species:ncbi:9606">patients</span>
###xml 559 567 <span type="species:ncbi:9606">patients</span>
###xml 609 617 <span type="species:ncbi:9606">patients</span>
###xml 663 671 <span type="species:ncbi:9606">patients</span>
###xml 837 845 <span type="species:ncbi:9606">patients</span>
###xml 991 999 <span type="species:ncbi:9606">patients</span>
###xml 1172 1180 <span type="species:ncbi:9606">patients</span>
###xml 1518 1526 <span type="species:ncbi:9606">patients</span>
Therefore, we performed ELISA to determine levels of pro-inflammatory TNF-alpha and anti-inflammatory IL-10 and IL-18 by using the same plasma samples in which the miRNA detection was performed. We found significant differences in expression levels between sepsis patients and controls (p = 0.026; p = 6.0E-04 and p = 6.8E-04, respectively) (Table 3), and these levels correlated with the plasma levels of miR-150 in patients and controls (Figures 3B). These data confirmed the imbalance between pro-inflammatory and anti-inflammatory cytokines in our sepsis patients, further confirming the selection of the patients for this study. Supporting the separation of patients according to miR-150 expression based on miR-192 normalization levels in plasma, we found that IL-18 expression was markedly different between the two categories of patients (greater than 8.5 ratio versus less than 8.5 ratio). Therefore, we computed a ratio between IL-18 ELISA assay expression and miR-150 expression: patients with miR-150/miR-192 fold difference less than 8.5 provided an IL-18/miR-150 ratio statistically significantly higher (more than 10 times higher, p<0.05) than the group of patients with miR-150/miR-192 expression of more than 8.5 (Figure 4). Although we did not ruled out a casual association by performing functional studies to prove the direct interaction between miR-150 and one/several cytokines, these data suggest a possible functional correlation between miR-150 plasma levels and cytokine expression in sepsis patients and that the plasma levels ratio for miR-150/interleukin-18 can be used for assessing the severity of the sepsis.
###end p 49
###begin title 50
###xml 60 68 <span type="species:ncbi:9606">Patients</span>
Ratio Between IL-18 and miR-150/miR-192 in Plasma of Sepsis Patients.
###end title 50
###begin p 51
###xml 49 56 49 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 77 84 77 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-192</italic>
###xml 168 175 168 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 245 252 245 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 382 389 382 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 438 439 438 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 113 121 <span type="species:ncbi:9606">Patients</span>
###xml 231 239 <span type="species:ncbi:9606">Patients</span>
###xml 368 376 <span type="species:ncbi:9606">patients</span>
A ratio between IL-18 ELISA assay expression and miR-150 expression based on miR-192 normalization was computed. Patients were separated into two groups related to the miR-150 expression before the threshold was established (8.5). Patients with miR-150 fold difference less than 8.5 provided an IL-18/miR-150 ratio statistically significantly higher than the group of patients with miR-150 expression of more than 8.5 (P<0.05 by two-side t-test). Mean Ct +/- standard deviation have been reported.
###end p 51
###begin title 52
Cytokine measurements from Septic Shock cases and Controls.
###end title 52
###begin p 53
Definition of abbreviations: <DL = less than the detectable limit of 4 pg/ml for TNF-alpha or 5 pg/ml for IL-10 and IL-18.
###end p 53
###begin p 54
###xml 189 210 189 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Materials and Methods</xref>
###xml 157 165 <span type="species:ncbi:9606">patients</span>
Displayed are the plasma cytokine determinations quantified by chemiluminescence in picograms per millimeter (median+/-range). The actual number of analyzed patients and controls are as in Materials and Methods.
###end p 54
###begin title 55
Discussion
###end title 55
###begin p 56
###xml 275 282 275 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 85 93 <span type="species:ncbi:9606">patients</span>
In the present prospective study we interrogated miRNA expression in a set of sepsis patients and found, by performing genome-wide profiling by microarray in leukocytes followed by quantitative reverse transcription-polymerase chain reaction (qRT-PCR) on plasma samples that miR-150 is significantly down regulated in respect with healthy controls levels and can be used for assessing the severity of the sepsis.
###end p 56
###begin p 57
###xml 394 397 394 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007405-Hotchkiss1">[1]</xref>
###xml 399 403 399 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007405-Libert1">[26]</xref>
###xml 854 861 854 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 863 870 863 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-182</italic>
###xml 876 886 876 886 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-342-5p</italic>
###xml 1027 1035 1027 1035 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1271 1275 1271 1275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007405-Schmidt1">[27]</xref>
###xml 1363 1371 1363 1371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-146b</italic>
###xml 1373 1380 1373 1380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 1382 1389 1382 1389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-342</italic>
###xml 1395 1401 1395 1401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">let-7g</italic>
###xml 1437 1444 1437 1444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-143</italic>
###xml 1446 1450 1446 1450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007405-Schmidt1">[27]</xref>
###xml 1458 1465 1458 1465 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 1504 1511 1504 1511 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1661 1665 1661 1665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007405-Xiao1">[28]</xref>
###xml 1728 1735 1728 1735 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 1807 1813 1807 1813 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-21</italic>
###xml 1916 1920 1916 1920 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007405-Fredriksson1">[29]</xref>
###xml 226 234 <span type="species:ncbi:9606">patients</span>
###xml 263 271 <span type="species:ncbi:9606">patients</span>
###xml 354 362 <span type="species:ncbi:9606">patients</span>
###xml 511 519 <span type="species:ncbi:9606">patients</span>
###xml 943 951 <span type="species:ncbi:9606">patients</span>
###xml 1051 1056 <span type="species:ncbi:9606">human</span>
###xml 1761 1769 <span type="species:ncbi:9606">patients</span>
###xml 1854 1862 <span type="species:ncbi:9606">patients</span>
This study is novel in several aspects. First, it addresses a significant medical condition, the sepsis, from a new perspective-the involvement of small non-coding RNAs. Sepsis is the major cause of death among critically ill patients in ICU. Total mortality for patients with acute postoperative sepsis is about 30%-35%; however, the mortality rate for patients with severe sepsis is over 50% [1], [26]. Consequently, severe sepsis is a disease in the need for critical care resources. We found that in sepsis patients the microRNoma (defined as the full spectrum of expressed miRNAs) is different from that in healthy controls, both in leukocytes (considered the cells involved in the immune disturbances characteristic of sepsis) and plasma on the first day of admission to the ICU. We found by microarray or qRT-PCR that the levels of three miRNAs - miR-150, miR-182, and miR-342-5p - are at least twice as dysregulated in leukocytes from patients than in those from healthy controls. Supporting these findings is a recent in vitro profile of the human leukocyte miRNA response to endotoxemia in which leukocyte RNA was isolated from venous blood samples obtained from three healthy male volunteers before and 4 h after LPS infusion and profiled for miRNA expression [27]. Five miRNAs consistently responded to LPS infusion, four of which were downregulated (miR-146b, miR-150, miR-342, and let-7g) and one of which was upregulated (miR-143) [27]. Also, miR-150 was found to control c-Myb expression in vivo in a dose-dependent manner over a narrow range of miRNA and c-Myb concentrations, and this dramatically affected lymphocyte development and response [28]. These data further strengthen the functional significance of miR-150 downregulation in sepsis patients. Furthermore, abnormal processing of miR-21 transcript was recently reported in ICU patients suffering from sepsis-induced multiple organ failure [29], expanding the spectrum of miRNA alterations in sepsis.
###end p 57
###begin p 58
###xml 219 223 219 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007405-Cortez1">[14]</xref>
###xml 344 351 344 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 449 456 449 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 717 721 717 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007405-Minne1">[30]</xref>
###xml 791 798 791 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 825 832 825 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-192</italic>
###xml 978 985 978 985 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-182</italic>
###xml 990 1000 990 1000 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-342-5p</italic>
###xml 311 319 <span type="species:ncbi:9606">patients</span>
###xml 390 398 <span type="species:ncbi:9606">patients</span>
###xml 545 552 <span type="species:ncbi:9606">patient</span>
Second, the recent identification of miRNAs in serum and plasma from healthy individuals and individuals with pathologic conditions, such as cancer, opens up the possibility of exploring miRNAs as biomarkers of disease [14]. To our knowledge, this is the first report of miRNA measurement in plasma from sepsis patients. We found not only that miR-150 levels are significantly different in patients and healthy controls, but also that the levels of miR-150 correlate with SOFA scores (but not with WBC). SOFA is a scoring system used to track a patient's status while in the ICU; it is based on six different scores, one each for the respiratory, cardiovascular, hepatic, coagulation, renal, and neurological systems [30]. We identified a ratio between the quantitative RT-PCR expression of miR-150 and a nonvariable control miR-192 that can be used to assess the severity of sepsis based on its correlation with the SOFA score. Additional candidates for large studies could be miR-182 and miR-342-5p that we found differentially expressed in sepsis versus control leukocytes.
###end p 58
###begin p 59
###xml 299 303 299 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007405-Hotchkiss2">[31]</xref>
###xml 304 308 304 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007405-Hotchkiss4">[33]</xref>
###xml 444 451 444 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 591 598 591 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 690 697 690 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-155</italic>
###xml 697 701 697 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007405-Baltimore1">[34]</xref>
###xml 706 713 706 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-125</italic>
###xml 713 717 713 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007405-Tili2">[35]</xref>
###xml 719 726 719 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 847 854 847 854 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 120 128 <span type="species:ncbi:9606">patients</span>
###xml 906 914 <span type="species:ncbi:9606">patients</span>
Finally, we revealed a new potential pathogenetic mechanism explaining some of the immune system dysfunctions in sepsis patients. The malfunction of regulatory mechanisms during sepsis can result in a loss of control of inflammation, eventually leading to profound immunosuppression and host damage [31]-[33]. Our study points to a miRNA regulation of pro- and anti-inflammatory genes involved in sepsis. We found that the expression levels of miR-150 correlated with those of main immune response genes, such as TNF-alpha, IL-10, and IL-18. Furthermore, the putative spectrum of targets of miR-150 is highly enriched in genes involved in immune system functions. Therefore, in addition to miR-155[34] and miR-125[35], miR-150 could be one of the main regulatory miRNAs of immune function, and our study unraveled the clinical significance of the miR-150 expression correlation with cytokine expression in patients with sepsis.
###end p 59
###begin p 60
###xml 523 530 523 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 46 51 <span type="species:ncbi:9606">human</span>
###xml 436 444 <span type="species:ncbi:9606">patients</span>
###xml 621 629 <span type="species:ncbi:9606">patients</span>
###xml 772 780 <span type="species:ncbi:9606">patients</span>
###xml 963 971 <span type="species:ncbi:9606">patients</span>
In conclusion, although the functions of most human miRNAs have yet to be discovered, miRNAs have emerged as key regulators of gene expression. The present data support the hypothesis that miRNAs are main regulators of the immune system, and abnormal expression has been found and can be used as a diagnostic and prognostic marker in immune disease. Sepsis is the newest addition to the long list of disease states proved by studies in patients to be linked to abnormal miRNA expression. One of the important regulators is miR-150, and this is significantly abnormally expressed in both leukocytes and plasma from sepsis patients. Our study is the first to identify a specific miRNA profile and to interrogate about the clinical significance of miRNA variations in sepsis patients. Due to the limited number of cases originating in the same center and to the bias toward intra-abdominal causes of sepsis, larger multi-institutional studies with higher numbers of patients will establish the final prognostic significance of our initial findings.
###end p 60
###begin title 61
Supporting Information
###end title 61
###begin p 62
###xml 178 185 178 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 437 444 437 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
###xml 449 456 449 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-192</italic>
White blood count (WBC) and miR-150/miR-192 relative expression plot. No correlation was found in 23 sepsis samples (the WBC was missing for one sample) after standardization of miR-150 relative expression values and WBC values meaning that miR-150/miR-192 ratio is not just a biomarker for presence or absence of circulating leukocytes in sepsis. The standard values were derived by subtracting the mean of the relative expressions for miR-150 and miR-192 and mean of the WBC, respectively from each individual relative expression value and WBC value, respectively, and then dividing the difference by the standard deviation, calculated for each one of the data series.
###end p 62
###begin p 63
(2.61 MB TIF)
###end p 63
###begin p 64
Click here for additional data file.
###end p 64
###begin p 65
###xml 250 257 250 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-150</italic>
miR-150/miR-192 relative expression correlates with sepsis grade. The mean +/- standard deviation of miR-150/miR-192 fold difference related to sepsis grade (labeled as sepsis, SP, severe sepsis, SSP, and septic shock, SoP) is reported. As expected, miR-150 relative expression is higher in low sepsis grade samples (SP). P values were not statistically significant, probably due to the limited number of analyzed samples.
###end p 65
###begin p 66
(1.98 MB TIF)
###end p 66
###begin p 67
Click here for additional data file.
###end p 67
###begin p 68
###xml 55 59 <span type="species:ncbi:261200">Sora</span>
We wish to thank Dr. Ileana Constantinescu and Mihaela Sora for initial samples processing. We also thank Sue Moreau from the Department of Scientific Publications at The University of Texas M. D. Anderson Cancer Center for expert editorial assistance.
###end p 68
###begin title 69
References
###end title 69
###begin article-title 70
The pathophysiology and treatment of sepsis.
###end article-title 70
###begin article-title 71
Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine.
###end article-title 71
###begin article-title 72
Rapid increase in hospitalization and DEADality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003.
###end article-title 72
###begin article-title 73
Relaparotomy for suspected intraperitoneal sepsis after abdominal surgery.
###end article-title 73
###begin article-title 74
###xml 83 91 <span type="species:ncbi:9606">Patients</span>
Postoperative Bacterial/Fungal Infections: A Challenging Problem in Critically Ill Patients after Abdominal Surgery.
###end article-title 74
###begin article-title 75
###xml 23 28 <span type="species:ncbi:9606">human</span>
MicroRNA signatures in human cancers.
###end article-title 75
###begin article-title 76
MicroRNAs-The micro steering wheel of tumor metastases.
###end article-title 76
###begin article-title 77
microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder.
###end article-title 77
###begin article-title 78
MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy.
###end article-title 78
###begin article-title 79
MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha.
###end article-title 79
###begin article-title 80
###xml 43 48 <span type="species:ncbi:9606">human</span>
MicroRNA expression profiles predictive of human renal allograft status.
###end article-title 80
###begin article-title 81
The functions of animal microRNAs.
###end article-title 81
###begin article-title 82
Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock.
###end article-title 82
###begin article-title 83
MicroRNA identification in plasma and serum: a novel tool to diagnose and monitor diseases.
###end article-title 83
###begin article-title 84
###xml 22 27 <span type="species:ncbi:9606">human</span>
Elevation of IL-18 in human sepsis.
###end article-title 84
###begin article-title 85
###xml 46 54 <span type="species:ncbi:9606">patients</span>
###xml 96 104 <span type="species:ncbi:9606">patients</span>
Interleukin-18 plasma levels are increased in patients with sepsis compared to severely injured patients.
###end article-title 85
###begin article-title 86
###xml 62 70 <span type="species:ncbi:9606">patients</span>
IL-18 level correlates with development of sepsis in surgical patients.
###end article-title 86
###begin article-title 87
Wnt5A/CaMKII signaling contributes to the inflammatory response of macrophages and is a target for the antiinflammatory action of activated protein C and interleukin-10.
###end article-title 87
###begin article-title 88
Wnt pathway: a new role in regulation of inflammation.
###end article-title 88
###begin article-title 89
Insulin Resistance and beta Cell Function As Prognostic Indicator in Multi-Organ Dysfunction Syndrome.
###end article-title 89
###begin article-title 90
###xml 66 72 <span type="species:ncbi:10090">murine</span>
Insulin therapy induces changes in the inflammatory response in a murine 2-hit model.
###end article-title 90
###begin article-title 91
Multiple TLRs activate EGFR via a signaling cascade to produce innate immune responses in airway epithelium.
###end article-title 91
###begin article-title 92
The TSC-mTOR signaling pathway regulates the innate inflammatory response.
###end article-title 92
###begin article-title 93
Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production.
###end article-title 93
###begin article-title 94
###xml 110 115 <span type="species:ncbi:9606">human</span>
###xml 171 179 <span type="species:ncbi:9606">patients</span>
Up-regulation of interleukin-10 mRNA expression in peripheral leukocytes predicts poor outcome and diminished human leukocyte antigen-DR expression on monocytes in septic patients.
###end article-title 94
###begin article-title 95
Inflammation: A nervous connection.
###end article-title 95
###begin article-title 96
###xml 23 28 <span type="species:ncbi:9606">human</span>
In vivo profile of the human leukocyte microRNA response to endotoxemia.
###end article-title 96
###begin article-title 97
MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb.
###end article-title 97
###begin article-title 98
###xml 76 84 <span type="species:ncbi:9606">patients</span>
Dysregulation of mitochondrial dynamics and the muscle transcriptome in ICU patients suffering from sepsis-induced multiple organ failure.
###end article-title 98
###begin article-title 99
Evaluation of SOFA-based models for predicting mortality in the ICU: A systematic review.
###end article-title 99
###begin article-title 100
Apoptosis and caspases regulate death and inflammation in sepsis.
###end article-title 100
###begin article-title 101
###xml 94 100 <span type="species:ncbi:9606">humans</span>
Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans.
###end article-title 101
###begin article-title 102
###xml 54 62 <span type="species:ncbi:9606">patients</span>
Depletion of dendritic cells, but not macrophages, in patients with sepsis.
###end article-title 102
###begin article-title 103
MicroRNAs: new regulators of immune cell development and function.
###end article-title 103
###begin article-title 104
Expression and function of micro-RNAs in immune cells during normal or disease state.
###end article-title 104
###begin p 105
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 105
###begin p 106
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: GAC was supported as a Fellow of The University of Texas M. D. Anderson Research Trust, a Fellow of The University of Texas System Regents Research Scholar, and by the Ladjevardian Regents Research Scholar Fund. MN was supported by funding from the Italian Ministry of University and Research and the Italian Ministry of Health. CV was supported by grant CEEX 187/2006 (The Program for Excellence in Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 106

